Latest News
-
October 23, 2025 | News
Crystalys Therapeutics begins Phase III trials for gout treatment
-
October 23, 2025 | News
Biotechs brush off sector headwinds in venture financing rebound
-
October 21, 2025 | Press Releases
Crystalys Therapeutics Advances Phase 3 Trials of Dotinurad for the Treatment of Gout with Dosing of First Patients
-
October 1, 2025 | News
Crystalys launches with $205M Series A financing